Dyadic International DYAI
NASDAQ DYAI
$0.69 -0.01 (-1.43%)
At close: Aug 21, 2026 · 4:00 PM EDT

Dyadic International (DYAI) Change in Acquisitions & Divestments (2018 - 2026)

Dyadic International (DYAI) posted Change in Acquisitions & Divestments of $1.8 million for Q1 2026, up 37.84% sequentially from $1.3 million in Q4 2025, and down 5.58% YoY from $1.9 million in Q1 2025.

Dyadic International (DYAI) Change in Acquisitions & Divestments (2018 - 2026) Analysis & Trends

Dyadic International has reported Change in Acquisitions & Divestments for 9 years, with the latest figure at $1.8 million in Q1 2026.

  • Quarterly Change in Acquisitions & Divestments fell 5.58% year-over-year to $1.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.9 million (down 8.08% YoY) and the FY2025 annual result came in at $6.0 million, up 11.62% from the prior year.
  • Change in Acquisitions & Divestments climbed to $1.8 million in Q1 2026 per DYAI's latest filing, from $1.3 million in the prior quarter.
  • Over five years, Change in Acquisitions & Divestments peaked at $4.5 million in Q1 2022 and troughed at $624010.0 in Q3 2025.
  • A 5-year average of $1.9 million and a median of $1.9 million in 2025 frame the typical range for Change in Acquisitions & Divestments.
  • The sharpest annual moves came in 2022 and 2023: Change in Acquisitions & Divestments sank 99.92% in 2022, then surged 281.0% in 2023.
  • Over 5 years, Change in Acquisitions & Divestments stood at $2.0 million in 2022, then tumbled by 61.25% to $775000.0 in 2023, then jumped by 240.0% to $2.6 million in 2024, then tumbled by 49.54% to $1.3 million in 2025, then soared by 37.84% to $1.8 million in 2026.
  • According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $1.8 million, $1.3 million, and $624010.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Dyadic International 19.98 Mn 19.98 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 1.83 Mn
Mar 31, 2026 1.83 Mn
Dec 31, 2025 1.33 Mn
Dec 31, 2025 1.33 Mn
Sep 30, 2025 624,010.00
Sep 30, 2025 624,010.00
Jun 30, 2025 2.14 Mn
Jun 30, 2025 2.14 Mn
Mar 31, 2025 1.94 Mn
Mar 31, 2025 1.94 Mn
Dec 31, 2024 2.64 Mn
Dec 31, 2024 2.64 Mn
Sep 30, 2024 1.23 Mn
Sep 30, 2024 1.23 Mn
Jun 30, 2024 646,000.00
Jun 30, 2024 646,000.00
Mar 31, 2024 900,000.00
Mar 31, 2024 900,000.00
Dec 31, 2023 775,000.00
Dec 31, 2023 775,000.00